EPHA2, EPHA4, and EPHA7 Expression in Triple-Negative Breast Cancer

EPHA2, EPHA4, and EPHA7 Expression in Triple-Negative Breast Cancer

Ongoing research continues to elucidate the complex role of ephrin receptors (EPHs) and their ligands (ephrins) in breast cancer pathogenesis, with their varying expression patterns implied to have an important impact on patients’ outcome. The current study aims to investigate the clinical significa...

Full description

Bibliographic Details
Main Authors: Ilias Nikas, Constantinos Giaginis, Kalliopi Petrouska, Paraskevi Alexandrou, Artemis Michail, Panagiotis Sarantis, Gerasimos Tsourouflis, Eugene Danas, Alexandros Pergaris, Panagiotis K. Politis, Lydia Nakopoulou, Stamatios Theocharis
Format: Article
Language:English
Published: MDPI AG 2022-02-01
Series:Diagnostics
Subjects:
biomarker
basal-like breast cancer
EPH
ephrin
targeted therapy
Online Access:https://www.mdpi.com/2075-4418/12/2/366

Internet

https://www.mdpi.com/2075-4418/12/2/366

Similar Items